Evogene Ltd
EVGN1.080USD
-0.020-1.82%
終値 02/06, 16:00（ET）15分遅れの株価
9.41M時価総額
損失額直近12ヶ月PER
詳細情報 Evogene Ltd 企業名
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Evogene Ltdの企業情報
企業コードEVGN
会社名Evogene Ltd
上場日Jun 11, 2007
最高経営責任者「CEO」Ember (Brian)
従業員数117
証券種類Ordinary Share
決算期末Jun 11
本社所在地13 Gad Feinstein Street
都市REHOVOT
証券取引所NASDAQ OMX - NASDAQ BASIC
国Israel
郵便番号7638517
電話番号97289311900
ウェブサイトhttps://evogene.com/
企業コードEVGN
上場日Jun 11, 2007
最高経営責任者「CEO」Ember (Brian)
Evogene Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Mark Kapel
Mr. Mark Kapel
Executive Vice President - Technology
Executive Vice President - Technology
--
--
Mr. Ziv Kop
Mr. Ziv Kop
Independent Director
Independent Director
--
--
Prof. Adrian Percy
Prof. Adrian Percy
Independent Director
Independent Director
--
--
Dr. Elran Hilel Haber
Dr. Elran Hilel Haber
Chief Executive Officer of Biomica Limited
Chief Executive Officer of Biomica Limited
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
収益内訳
通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2024
FY2018
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
Other
4.00M
47.00%
United States
3.92M
46.00%
Israel
595.77K
7.00%
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Sun, Feb 1
更新時刻: Sun, Feb 1
株主統計
種類
株主統計
株主統計
比率
Recanati (Leon Yehuda)
0.96%
Citadel Advisors LLC
0.66%
Jane Street Capital, L.L.C.
0.45%
Morgan Stanley & Co. LLC
0.35%
Two Sigma Investments, LP
0.13%
他の
97.45%
株主統計
株主統計
比率
Recanati (Leon Yehuda)
0.96%
Citadel Advisors LLC
0.66%
Jane Street Capital, L.L.C.
0.45%
Morgan Stanley & Co. LLC
0.35%
Two Sigma Investments, LP
0.13%
他の
97.45%
種類
株主統計
比率
Individual Investor
0.96%
Research Firm
0.94%
Hedge Fund
0.79%
Investment Advisor/Hedge Fund
0.17%
Investment Advisor
0.14%
他の
97.00%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
51
144.62K
9.61%
--
2025Q3
53
144.62K
9.93%
--
2025Q2
54
144.62K
9.94%
-290.86K
2025Q1
54
436.41K
15.76%
-409.22K
2024Q4
55
411.93K
12.75%
-150.59K
2024Q3
55
562.52K
10.21%
+159.81K
2024Q2
56
414.42K
108.89%
-12.34K
2024Q1
61
426.75K
10.84%
-122.17K
2023Q4
68
460.98K
18.51%
-27.27K
2023Q3
74
506.57K
13.57%
+395.44K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Recanati (Leon Yehuda)
83.89K
0.96%
--
--
Mar 17, 2025
Citadel Advisors LLC
57.58K
0.66%
+36.21K
+169.43%
Sep 30, 2025
Jane Street Capital, L.L.C.
39.42K
0.45%
+24.40K
+162.42%
Sep 30, 2025
Morgan Stanley & Co. LLC
30.32K
0.35%
+15.16K
+99.95%
Sep 30, 2025
Two Sigma Investments, LP
11.41K
0.13%
-9.68K
-45.91%
Sep 30, 2025
BNP Paribas Securities Corp. North America
11.23K
0.13%
-2.89K
-20.45%
Sep 30, 2025
P&S Vermögensberatungs AG Performance & Sicherheit
10.00K
0.11%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
4.20K
0.05%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
1.20K
0.01%
-5.53K
-82.15%
Sep 30, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
日付
配当落ち日
種類
比率
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
Aug 03, 2022
Merger
10→1
